Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. ultimate formulations, inc.
WARNING LETTER
•ultimate formulations, inc. •April 2, 2010

ultimate formulations, inc. – FDA Warning Letter, Apr 2, 2010

Record Details

On March 17-April 2, 2010, the FDA inspected Ultimate Formulations, Inc., dba Best Formulations, finding significant cGMP violations (21 CFR Part 111) for dietary supplements, rendering products adulterated under Section 402(g)(1) of the Act.

Key violations include: 1. **Failure to Determine Product Specifications (21 CFR 111.73, 111.75(c)):** The firm did not test every finished batch for strength or composition for numerous softgel, tablet, capsule, powder, and tea products. The company's proposed "Quality Agreement" shifting responsibility to customers and testing only two random lots annually was deemed inadequate, as the manufacturer is solely responsible for ensuring specifications are met. 2. **Inadequate Master Manufacturing Records (MMR) (21 CFR 111.205(b)(1), 111.205(b)(2), 111.210(h)):** MMRs for several products lacked specifications for critical control points, failed to establish controls to ensure specifications were met, and omitted required written instructions for manufacturing processes, including corrective action plans for out-of-specification (OOS) results (e.g., selenium levels, size/shape deviations). The firm's proposed "notify Supervisor" instruction was insufficient. 3

Company
ultimate formulations, inc.
Inspection date
April 2, 2010
Product type
Food
Office
Los Angeles District Office
People
  • Alonza E. Cruse (Director)
  • Blake Bevill (Director)
  • William S. Vitale (Compliance Officer)
View Company Profile

ID · f1eabd5c-3a0b-4673-b333-233c32f71553

Violation Codes10
21 CFR 11121 U.S.C. 342(g)(1)21 CFR 111.7321 CFR 111.75(c)21 CFR 111.205(b)(1)21 CFR 111.205(b)(2)21 CFR 111.210(h)(1)21 CFR 111.210(h)(3)21 CFR 111.210(h)(5)21 CFR 111.210(f)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore ultimate formulations, inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.